Biologics plus partial tube-feeding for Crohn’s disease
Part of Digestive system clinical trials.
This study tests whether starting adalimumab along with partial enteral (tube or drink) nutrition helps control active Crohn’s disease. It may help reduce symptoms and inflammation compared with standard care alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 16 or older and have active Crohn’s disease right now (per Crohn’s disease activity score).
- You are about to start standard adalimumab injections (a treatment schedule your clinic will set).
- You can give written consent, and you are not pregnant or breastfeeding.
- You do not have a stoma, short bowel syndrome, or major fistulas or severe scar-like narrowing (strictures) that cause symptoms.
- You haven’t used anti-TNF biologic treatment before, and you haven’t had biologics or other mouth medications for Crohn’s in the last 12 weeks.
- You haven’t had certain medicines recently: steroids above those limits, a new immunomodulator in 8 weeks, or oral antibiotics in 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special diet (CDED) combined with anti-TNF medication (infliximab or adalimumab) to see if it's safe and works better for active Crohn's disease. It may help if you haven't used these drugs before and can follow the diet.
This trial tests whether people with Crohn’s disease or ulcerative colitis who are currently well-controlled can safely use less-frequent anti-TNF medicine. It may help reduce treatment intensity while keeping inflammation under control.
This study tests whether combining a specific diet with biologic medicines can reduce active inflammation and symptoms of Crohn’s disease. It may help people who still have active disease in the bowel despite prior care.
This trial tests whether a special diet (called an exclusion diet) plus a nutritional supplement can change your gut bacteria and help control active Crohn's disease. It may be a good option if you have mild-to-moderate symptoms and want to try a food-based approach before stronger medications.
This trial compares a steroid called prednisolone to a special diet (aCDED with PEN) for treating Crohn's disease flare-ups. It aims to see which approach helps improve quality of life.
This Phase 4 trial tests which type of biologic medicine works best as the first treatment for people with moderate-to-severe Crohn’s that mainly affects the ileum. It may help you and your care team choose a more effective first option, based on which strategy leads to better control of symptoms and intestinal inflammation.
Hear when a new Crohn Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.